Hosted on MSN7d
Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced in Q4 CY2024, with sales up 7.5% year on year to $12.34 ...
Reuters7d
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall
Bristol Myers expands cost-cutting program by $2 billion Drugmaker sees loss of exclusivity of some cancer drugs in 2025 Posts better-than-expected fourth-quarter earnings Feb 6 (Reuters ...